ES8607949A1 - Un procedimiento para preparar un derivado de dihidropiridazinona - Google Patents

Un procedimiento para preparar un derivado de dihidropiridazinona

Info

Publication number
ES8607949A1
ES8607949A1 ES539446A ES539446A ES8607949A1 ES 8607949 A1 ES8607949 A1 ES 8607949A1 ES 539446 A ES539446 A ES 539446A ES 539446 A ES539446 A ES 539446A ES 8607949 A1 ES8607949 A1 ES 8607949A1
Authority
ES
Spain
Prior art keywords
formula
procedure
reaction
dihydropiridazinone
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES539446A
Other languages
English (en)
Spanish (es)
Other versions
ES539446A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES8607949A1 publication Critical patent/ES8607949A1/es
Publication of ES539446A0 publication Critical patent/ES539446A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22Nitrogen and oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/28Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Hydrogenated Pyridines (AREA)
ES539446A 1984-01-13 1985-01-10 Un procedimiento para preparar un derivado de dihidropiridazinona Expired ES8607949A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848400863A GB8400863D0 (en) 1984-01-13 1984-01-13 Chemical compounds

Publications (2)

Publication Number Publication Date
ES8607949A1 true ES8607949A1 (es) 1986-06-01
ES539446A0 ES539446A0 (es) 1986-06-01

Family

ID=10554924

Family Applications (3)

Application Number Title Priority Date Filing Date
ES539446A Expired ES8607949A1 (es) 1984-01-13 1985-01-10 Un procedimiento para preparar un derivado de dihidropiridazinona
ES549629A Expired ES8703846A1 (es) 1984-01-13 1985-12-05 Un procedimiento para preparar derivados de dihidropiridazi-nona
ES554965A Expired ES8706645A1 (es) 1984-01-13 1986-05-14 Un procedimiento para preparar derivados de dihidropiridazinona

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES549629A Expired ES8703846A1 (es) 1984-01-13 1985-12-05 Un procedimiento para preparar derivados de dihidropiridazi-nona
ES554965A Expired ES8706645A1 (es) 1984-01-13 1986-05-14 Un procedimiento para preparar derivados de dihidropiridazinona

Country Status (31)

Country Link
US (1) US4654342A (enExample)
EP (1) EP0150937B1 (enExample)
JP (3) JPS60158181A (enExample)
KR (1) KR920006781B1 (enExample)
CN (1) CN85101722A (enExample)
AT (1) ATE37179T1 (enExample)
AU (1) AU572252B2 (enExample)
CA (2) CA1251209A (enExample)
CS (1) CS248731B2 (enExample)
DD (1) DD231350A5 (enExample)
DE (1) DE3564941D1 (enExample)
DK (1) DK162519C (enExample)
ES (3) ES8607949A1 (enExample)
FI (1) FI850140L (enExample)
GB (1) GB8400863D0 (enExample)
GR (1) GR850068B (enExample)
HU (1) HU193591B (enExample)
IE (1) IE57969B1 (enExample)
IL (1) IL74031A (enExample)
JO (1) JO1351B1 (enExample)
MY (1) MY100124A (enExample)
NO (1) NO850129L (enExample)
NZ (1) NZ210816A (enExample)
PH (1) PH22136A (enExample)
PL (1) PL147123B1 (enExample)
PT (1) PT79819B (enExample)
RO (1) RO92607A (enExample)
SU (1) SU1396963A3 (enExample)
WO (1) WO1985003076A1 (enExample)
ZA (1) ZA85251B (enExample)
ZW (1) ZW385A1 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1251448A (en) * 1985-03-27 1989-03-21 William J. Coates Pyridazinone derivatives
AU581324B2 (en) * 1985-07-05 1989-02-16 Smith Kline & French Laboratories Limited Substituted 6-phenyl-4,5-dihydro pyradazin-3-ones
GB8603780D0 (en) * 1986-02-15 1986-03-19 Smith Kline French Lab Chemical compounds
GB8722776D0 (en) * 1987-09-28 1987-11-04 Smith Kline French Lab Chemical compounds
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
AU2002254124A1 (en) 2001-02-27 2002-09-12 Mitokor Aryl-n-cyanoguanidines and methods related thereto
DE60213841T2 (de) * 2001-11-05 2007-02-15 Merck Patent Gmbh Hydrazono-malonitrile
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
US8980894B2 (en) * 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
AU2006311577B2 (en) 2005-11-09 2013-02-07 Zalicus Inc. Methods, compositions, and kits for the treatment of medical conditions
PL1951227T3 (pl) * 2005-11-14 2017-09-29 Boehringer Ingelheim Vetmedica Gmbh Zastosowania pimobendanu do leczenia bezobjawowej(utajonej) niewydolności serca
EP1920785A1 (en) * 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US8664252B2 (en) 2008-11-25 2014-03-04 Boehringer Ingelheim Vetmedica Gmbh Phosphodiesterase type III (PDE III) inhibitors or CA2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EA201391254A1 (ru) 2011-03-01 2014-02-28 Синерджи Фармасьютикалз Инк. Способ получения агонистов гуанилатциклазы c
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CN105764916B (zh) 2013-06-05 2021-05-18 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
PL3021832T3 (pl) 2013-07-19 2021-08-23 Boehringer Ingelheim Vetmedica Gmbh Konserwowana ciekła wodna kompozycja farmaceutyczna zawierająca eteryfikowane pochodne cyklodekstryny
EP3492106B1 (en) 2013-08-09 2021-02-17 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
BR122019024673B1 (pt) 2013-12-04 2023-04-11 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
CN104987310A (zh) * 2015-06-03 2015-10-21 青岛农业大学 左西孟旦的合成工艺
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN110117257B (zh) * 2018-02-05 2022-12-06 安徽省新星药物开发有限责任公司 一种含胍基的p2y12受体拮抗剂、制备方法及其用途
EP3972599B1 (en) 2019-05-21 2025-10-22 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822260A (en) * 1970-10-09 1974-07-02 American Cyanamid Co 6-(cyanophenyl)-4,5-dihydro-3(2h)-pyridazinones
BE791539A (fr) * 1971-11-19 1973-05-17 Basf Ag Dihydropyridazones, leur preparation et leurs utilisations therapeutiques
EP0030835B1 (en) * 1979-12-05 1983-05-11 Morishita Pharmaceutical Co. Ltd. Derivatives of 2-substituted-6-phenyl-3(2h)pyridazinone, their production and pharmaceutical compositions containing them
EP0059688B1 (de) * 1981-03-04 1985-05-15 Ciba-Geigy Ag Pyridazinone, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen und deren Verwendung
JPS58113180A (ja) * 1981-12-28 1983-07-05 Mitsui Toatsu Chem Inc ピリダジノン誘導体
JPS58140076A (ja) * 1982-02-09 1983-08-19 Mitsubishi Chem Ind Ltd ピリダジノン誘導体又はその塩類
DE3204375C2 (de) * 1982-02-09 1983-12-01 J. Rettenmaier & Söhne GmbH + Co, 7091 Holzmühle Verfahren zur Herabsetzung der Saugfähigkeit von Holz
DE3302021A1 (de) * 1983-01-22 1984-07-26 Basf Ag, 6700 Ludwigshafen 6-aryl-4,5-dihydro-3(2h)-pyridazinone, ihre herstellung und verwendung
AU581324B2 (en) * 1985-07-05 1989-02-16 Smith Kline & French Laboratories Limited Substituted 6-phenyl-4,5-dihydro pyradazin-3-ones

Also Published As

Publication number Publication date
US4654342A (en) 1987-03-31
NZ210816A (en) 1987-06-30
KR850005417A (ko) 1985-08-26
DD231350A5 (de) 1985-12-24
JO1351B1 (en) 1986-11-30
WO1985003076A1 (en) 1985-07-18
KR920006781B1 (ko) 1992-08-17
JPS63313776A (ja) 1988-12-21
FI850140A0 (fi) 1985-01-11
JPS60158181A (ja) 1985-08-19
CA1260471C (enExample) 1989-09-26
CS248731B2 (en) 1987-02-12
ES8706645A1 (es) 1987-07-01
GR850068B (enExample) 1985-05-03
ES554965A0 (es) 1987-07-01
SU1396963A3 (ru) 1988-05-15
DK162519B (da) 1991-11-11
DK9185A (da) 1985-07-14
FI850140A7 (fi) 1985-07-14
IE57969B1 (en) 1993-06-02
IL74031A (en) 1988-07-31
ZA85251B (en) 1986-08-27
DK162519C (da) 1992-03-30
ES539446A0 (es) 1986-06-01
CA1260471A (en) 1989-09-26
PL251516A1 (en) 1985-12-17
RO92607A (ro) 1987-11-30
IE850069L (en) 1985-07-13
PL147123B1 (en) 1989-04-29
DE3564941D1 (en) 1988-10-20
ZW385A1 (en) 1985-08-07
ATE37179T1 (de) 1988-09-15
AU3761185A (en) 1985-07-18
PH22136A (en) 1988-06-01
GB8400863D0 (en) 1984-02-15
JPS63313775A (ja) 1988-12-21
EP0150937A3 (en) 1985-08-21
AU572252B2 (en) 1988-05-05
CN85101722A (zh) 1987-01-31
CA1251209A (en) 1989-03-14
IL74031A0 (en) 1985-04-30
FI850140L (fi) 1985-07-14
HUT37128A (en) 1985-11-28
EP0150937A2 (en) 1985-08-07
NO850129L (no) 1985-07-15
MY100124A (en) 1989-12-18
ES8703846A1 (es) 1987-03-01
HU193591B (en) 1987-11-30
EP0150937B1 (en) 1988-09-14
PT79819A (en) 1985-02-01
ES549629A0 (es) 1987-03-01
PT79819B (en) 1987-01-07
DK9185D0 (da) 1985-01-08

Similar Documents

Publication Publication Date Title
ES8607949A1 (es) Un procedimiento para preparar un derivado de dihidropiridazinona
ES8704924A1 (es) Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofeno
ES8206491A1 (es) Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina.
AR245447A1 (es) Procedimiento para preparar derivados de 2,4-diamino-5-(biciclo-sustituido)metilpirimidinas.
ES8604226A1 (es) Procedimiento para preparar (2-oxo-1, 2, 3, 5-tetrahidroimidazo (2, 1-b) quinazolinil) oxialquilamidas
ES2076147T3 (es) Nuevos derivados de amina ciclicos, medicamento que contiene estos compuestos y procedimiento para su preparacion.
ES8704965A1 (es) Un procedimiento para la preparacion de un antibiotico de macrolida
ES8603883A1 (es) Procedimiento para preparar nuevos 2-fenil-imidazoles
ES8202816A1 (es) Un procedimiento para preparar diaminopiridinas
ES8306125A1 (es) Un procedimiento para la preparacion de derivados de fenil- piperacina.
ES8603497A1 (es) Procedimiento para preparar derivados de cefalosporina
ES8801618A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
ES8801222A1 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES8301978A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroaril-tiazoles.
ES8305755A1 (es) Procedimiento para preparar derivados de pirimidona.
ES8401042A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina.
ES8103745A1 (es) Procedimiento para la preparacion de derivados de pirido (2,1-b) quinazolinona
ES8404671A1 (es) Un procedimiento para la preparacion de derivados del acido fenoxialquilcarboxilico.
ES8301965A1 (es) Procedimiento para preparar derivados de acido quinolina- carboxilico
ES8104792A1 (es) Procedimiento para la preparacion de bis-amidas de acidos 5-amino-2,4,6-triyodo-isoftalicos
ES8607299A1 (es) Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimida- zo(2,1-b)quinazolinil)-oxialquilamidas
ES8300711A1 (es) Un procedimiento para la preparacion de un derivado cis-4,5-disustituidos de imidazolidin-2-ona opticamente activo.
ES8402557A1 (es) Esteres fenolicos.
ES8301883A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401